Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution and Crystallization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1027503C details a superior crystalline salt form of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo[cd]indole, offering enhanced purity and scalable manufacturing for CNS drug development.
Patent CN104628720A offers high purity moxifloxacin hydrochloride refining. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN102249998A reveals a high-yield synthesis route for Cisatracurium Besylate, offering superior purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN115850115B reveals high-purity Ruxolitinib intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.